The first episode of our three part series, Live from Psychedelic Science, focuses on research.  We interview five leaders in the field whose work runs the gamut from generating novel molecules to patient care.  We kick off the episode with back to back chemist entrepreneurs who work at the cutting edge of psychedelic drug development.  From there we hear from the psychedelics program manager at one of the world’s largest medical research institutions.  Next, we get an international perspective by engaging with Brazil’s leading clinical researcher of ayahuasca, pure DMT, and ketamine.  We close out the episode with an experienced integrative medicine doctor and patient advocate.